This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Derma Sciences Inc (DSCI)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 19.40M 6.50M 41.62M 17.11M
Receivables 8.76M 7.33M 7.09M 6.27M
Inventories 13.28M 16.47M 13.67M 10.53M
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 100.84M 49.53M 69.31M 41.23M
Property, Plant & Equipment, Gross 11.30M 10.31M 10.20M 9.38M
Accumulated Depreciation & Depletion 7.68M 7.36M 6.90M 5.89M
Property, Plant & Equipment, Net 3.61M 2.95M 3.30M 3.49M
Intangibles 12.82M 14.64M 17.13M 6.40M
Other Non-Current Assets 8.57M 8.00M 639.21K 378.82K
Total Non-Current Assets 38.45M 39.04M 34.53M 17.39M
Liabilities & Shareholder Equity
Total Assets 139.30M 88.58M 103.84M 58.62M
Accounts Payable 5.06M 4.52M 3.99M 4.00M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 11.51M 9.49M 8.13M 6.38M
Long Term Debt 0.00 0.00 268.52K 0.00
Deferred Income Taxes 1.70M 1.69M 1.74M 1.15M
Other Non-Current Liabilities 521.36K 242.32K 0.00 252.68K
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 2.22M 1.94M 2.00M 1.40M
Total Liabilities 13.73M 11.43M 10.13M 7.78M
Preferred Stock Equity 733.00 733.00 733.00 733.00
Common Stock Equity 125.56M 77.15M 93.71M 50.85M
Common Par 253.19K 173.47K 165.25K 105.78K
Additional Paid In Capital 228.34M 140.06M 132.16M 77.37M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -103.94M -64.17M -40.21M -28.14M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 911.56K 1.08M 1.59M 1.50M
Total Capitalization 125.56M 77.15M 93.98M 50.85M
Total Equity 125.56M 77.15M 93.71M 50.85M
Total Liabilities & Stock Equity 139.30M 88.58M 103.84M 58.62M
Total Common Shares Outstanding 25.32M 17.35M 16.52M 10.58M
Preferred Shares 73.33K 73.33K 73.33K 73.33K
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 24.58M 17.06M 12.49M 8.78M
Diluted Weighted Shares Outstanding 24.58M 17.06M 12.49M 8.78M
Number of Employees 299 258 237 212
Number of Part-Time Employees 4 4 7 2
DSCI News

DSCI Derma Sciences Inc

Analysts Ratings for DSCI

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 3
Moderate Buy 0 0 0 0
Hold 1 1 1 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET DSCI ANALYST REPORT

Brokerage Partners

DSCI Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs